Tryptophan metabolism and cardiac disease.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D003677:Deficiency Diseases / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D004699:Endocardium / Q000473:pathology; D005260:Female; D006168:Guinea Pigs; D006331:Heart Diseases / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D006339:Heart Rate / Q000187:drug effects; D006351:Heart Valves / Q000473:pathology; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008297:Male; D009206:Myocardium / Q000201:enzymology; D006005:Phosphorylases / Q000378:metabolism; D012701:Serotonin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D014364:Tryptophan / Q000378:metabolism*
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D006005:Phosphorylases